Panbela Therapeutics, Inc. Common Stock
PBLA
PBLA was delisted on the 6th of March, 2024.
6 hedge funds and large institutions have $1.17M invested in Panbela Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
15% more capital invested
Capital invested by funds: $1.02M → $1.17M (+$151K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMG
Brand Asset Management Group
Chesterfield,
Missouri
|
+$160K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$80.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$321K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$238K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $320K | +$321K | +4 | New |
|
|
EIM
2
Essex Investment Management
Boston,
Massachusetts
| $225K | – | – | – |
|
3
Verition Fund Management
Greenwich,
Connecticut
| $216K | – | – | – |
|
|
BAMG
4
Brand Asset Management Group
Chesterfield,
Missouri
| $203K | +$160K | +2 | New |
|
|
WVP
5
Worth Venture Partners
Fort Lee,
New Jersey
| $78K | -$321K | -4 | -80% |
|
|
6
Creative Planning
Overland Park,
Kansas
| $62K | +$80.2K | +1 | New |
|
7
Millennium Management
New York
| $41K | – | – | – |
|
8
Morgan Stanley
New York
| $18K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $11K | – | – | – |
|
|
CH
10
CVI Holdings
Wilmington,
Delaware
| – | -$238K | -3 | Closed |
|
PBLA Hedge Fund Activity: Q4 2020 in Review
6 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Panbela Therapeutics, Inc. Common Stock (PBLA) for Q4 2020, worth a combined $1.17M — up 15% from $1.02M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PBLA positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Brand Asset Management Group, opening a new position worth an estimated $160K. The largest seller was Worth Venture Partners, cutting an estimated $321K.
- 6 institutional investors held Panbela Therapeutics, Inc. Common Stock (PBLA) as of Q4 2020, up from 4 in Q3 2020.
- Funds reported $1.17M of Panbela Therapeutics, Inc. Common Stock stock for Q4 2020, up 15% quarter-over-quarter.
- 3 funds opened new Panbela Therapeutics, Inc. Common Stock positions in Q4 2020 and 1 closed out, a net change of +2 holders.
- The largest Panbela Therapeutics, Inc. Common Stock buyer in Q4 2020 was Brand Asset Management Group, an estimated $160K added.
- The largest Panbela Therapeutics, Inc. Common Stock seller in Q4 2020 was Worth Venture Partners, an estimated $321K sold.
Based on aggregated 13F filings for Q4 2020.